Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for exercise capacity in COPD patients with pulmonary hypertension
ISRCTN10877141Phase 2Completed
- Sponsor
- University of Dundee
- Start
- Sep 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH) comparing Tadalafil with Placebo (2 arms). Primary endpoint: Six-minute walk distance. Started Sep 2010; status: completed.
02
Drugs
tadalafil
03
Conditions
chronic obstructive pulmonary disease (COPD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on ISRCTN10877141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10877141.